Cargando…
Multidrug resistance protein 5 affects cell proliferation, migration and gemcitabine sensitivity in pancreatic cancer MIA Paca‑2 and PANC‑1 cells
Gemcitabine-based chemotherapy has been widely adopted as the standard and preferred chemotherapy regimen for treating advanced pancreatic cancer. However, the contribution of multidrug resistance protein 5 (MRP5) to gemcitabine resistance and pancreatic cancer progression remains controversial. In...
Autores principales: | He, Ji, Bugde, Piyush, Li, Jiawei, Biswas, Riya, Li, Siting, Yang, Xuewei, Tian, Fang, Wu, Zimei, Li, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696546/ https://www.ncbi.nlm.nih.gov/pubmed/37975256 http://dx.doi.org/10.3892/or.2023.8666 |
Ejemplares similares
-
MIA PaCa-2 and PANC-1 – pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors
por: Gradiz, Rui, et al.
Publicado: (2016) -
Berberine induces apoptosis via ROS generation in PANC-1 and MIA-PaCa2
pancreatic cell lines
por: Park, S.H., et al.
Publicado: (2014) -
Differentially Expressed microRNAs in MIA PaCa-2 and PANC-1 Pancreas Ductal Adenocarcinoma Cell Lines are Involved in Cancer Stem Cell Regulation
por: Shen, Ye, et al.
Publicado: (2019) -
Combination of dasatinib and gemcitabine reduces the ALDH1A1 expression and the proliferation of gemcitabine-resistant pancreatic cancer MIA PaCa-2 cells
por: DUONG, HONG-QUAN, et al.
Publicado: (2014) -
Transport-Mediated Oxaliplatin Resistance Associated with Endogenous Overexpression of MRP2 in Caco-2 and PANC-1 Cells
por: Biswas, Riya, et al.
Publicado: (2019)